[1]
Zaurito, P. et al. 2026. Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study. Scandinavian Journal of Urology. 61, 1 (Mar. 2026), 51–57. DOI:https://doi.org/10.2340/sju.v61.45652.